Immunotherapy Clinical Trials in Guangzhou, Guangdong
17 recruitingGuangzhou, Guangdong, China
Showing 1–17 of 17 trials
Recruiting
RATS Sleeve Lobectomy After Neo-Chemo-IO for NSCLC
Robotic SurgeryStage IIB-III NSCLCNeoadjuvant Chemoimmunotherapy+1 more
Shanghai Chest Hospital100 enrolled10 locationsNCT07541521
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
Stage IIB-III NSCLCNeoadjuvant ChemoimmunotherapyRobotic Pulmonary Resection
Shanghai Chest Hospital200 enrolled10 locationsNCT07528066
Recruiting
Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arterial Infusion Chemotherapy Combined With Targeted and Immunotherapy
Targeted TherapyImmunotherapyHepatocellular Carcinoma (HCC)+2 more
Nanfang Hospital, Southern Medical University90 enrolled1 locationNCT07436845
Recruiting
Phase 2
Adaptive Adjuvant Sintilimab Therapy Guided by MRD (ADAPT Lung)
MRDNSCLC (Non-small Cell Lung Cancer)II-IIIB Stages+1 more
Guangdong Association of Clinical Trials115 enrolled2 locationsNCT07120698
Recruiting
Phase 2
Oral Chemotherapy, Targeted Therapy and Immunotherapy With/Without Radiotherapy as 3rd- or Later-line Therapy for Advanced MSS/pMMR Colorectal Cancer
ChemotherapyTargeted TherapyImmunotherapy+2 more
Sun Yat-sen University57 enrolled1 locationNCT06764680
Recruiting
Phase 3
Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
Neoadjuvant TherapyImmunotherapyLocally Advanced Non-Small Cell Lung Cancer+1 more
Sun Yat-sen University497 enrolled1 locationNCT06734702
Recruiting
Phase 2
Probiotics in Advanced Urothelial Carcinoma
ImmunotherapyAdvanced Urothelial CarcinomaProbiotics
Sun Yat-sen University222 enrolled3 locationsNCT06904573
Recruiting
Phase 2
Neoadjuvant Toripalimab Plus Celecoxib for dMMR/MSI-H Locally Advanced Colorectal Cancer
Colorectal Cancer (CRC)PD-1 InhibitorNeoadjuvant Immunotherapy+2 more
Sun Yat-sen University105 enrolled1 locationNCT06903858
Recruiting
Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
Nasopharyngeal CarcinomaMulti-omics TechniqueRecurrent and Metastatic Nasopharyngeal Carcinoma+1 more
Sun Yat-sen University50 enrolled1 locationNCT06197776
Recruiting
Phase 2
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
Cervical CancerFertility PreservationNeoadjuvant Chemoimmunotherapy
Tongji Hospital40 enrolled2 locationsNCT06289062
Recruiting
Not Applicable
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
Hepatocellular CarcinomaImmunotherapySintilimab+2 more
Sun Yat-sen University30 enrolled1 locationNCT06070636
Recruiting
Phase 1Phase 2
Induced-T Cell Like NK Cellular Immunotherapy for Cancer Lack of MHC-I
Anti-cancer Cell ImmunotherapyT Cell and NK Cell
Second Affiliated Hospital of Guangzhou Medical University60 enrolled1 locationNCT03882840
Recruiting
Phase 1
GPC3/Mesothelin/Claudin18.2/GUCY2C/B7-H3/PSCA/PSMA/MUC1/TGFβ/HER2/Lewis-Y/AXL/EGFR-CAR-T Cells Against Cancers
Lung CancerCancerImmunotherapy+1 more
Second Affiliated Hospital of Guangzhou Medical University30 enrolled2 locationsNCT03198052
Recruiting
Phase 1
GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression
Hepatocellular CarcinomaImmunotherapySquamous Cell Lung Cancer+3 more
Second Affiliated Hospital of Guangzhou Medical University30 enrolled2 locationsNCT03198546
Recruiting
Phase 2
Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer
Neoadjuvant TherapyColon CancerImmunotherapy
Sun Yat-sen University55 enrolled1 locationNCT06014372
Recruiting
Plasma and Tissue SAA1 Levels in Cancer Patients to Predict Hyperprogression of Immunotherapy
ImmunotherapyBiomarkerHyperprogression
Nanfang Hospital, Southern Medical University374 enrolled5 locationsNCT06276088
Recruiting
The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
Lung CancerImmunotherapy
Guangdong Association of Clinical Trials100 enrolled1 locationNCT04286841